Plavix may only help smokers


New research suggests smokers may be the only people who see clinical benefit from taking Plavix.

There is ample evidence that suggests there is no benefit to taking Plavix. In fact, taking the drug could increase a person’s risk of experiencing a dangerous and life-threatening side effect like severe internal bleeding, heart attack, or stroke. According to a report at, researchers at Sinai Hospital of Baltimore have discovered a “substantial reduction” in morbidity and mortality rates among smokers. They found no such impact on non-smokers.

This study, published in an article in Journal of the American Medical Association, used several large-scale clinical trials to arrive at its conclusion.

Smokers gain some benefit from Plavix (clopidogrel) because the particularly dangerous habit incites a metabolism boost and the drug is broken down faster in this group of patients. The study authors certainly do not suggest physicians begin advising their patients to smoke.

Recent lawsuits have been filed by patients who have suffered adverse side effects to taking Plavix, believing it was more effective at preventing blood clots that can lead to heart attacks, stroke, and possibly death.  Many people also claim to have suffered ulcers while taking Plavix, a risk not commonly faced by people who take aspirin alone.

Plavix was once marketed as a “super aspirin” and taking it with the common over-the-counter medication only boosts its positive effects.